Note: Ingredients listed on restricted chemical lists
EC/CAS
202-859-9/100-51-6
Name of the chemical
Benzyl Alcohol
Concentration
2%
General Information
Version
1.0.0
Revision date
2019-02-22
Product name
Sodium Tetradecyl Sulfate Injection 3% (30 mg/mL) (in vials)
Product name
Sodium Tetradecyl Sulfate Injection 3% (30 mg/mL) (in vials)
Identification on the label/Trade name
None assigned
Product Synonyms
7-Ethyl-2-Methyl-4-undecyl sulfate sodium salt; 4-Undecanol, 7-ethyl-2-methyl, 7-Ethyl-2-Methyl-4-undecyl sulfate sodium salt; 4-Undecanol, 7-ethyl-2-methyl, hydrogen sulfate, sodium salt
Chemical name
Mixture - anionic surfactant
1.2.1 Relevant identified uses
Bulk formulated pharmaceutical mixture/Formulated pharmaceutical product/ of the substance or mixture packaged in final form for patient use; used in the treatment of varicose mixture and uses veins and hemorrhoids
Emergency telephone
+1 (800) 424-9300, +1 (703) 527-3887
Icons in SDS
Company Information
company name
Leucadia Pharmaceuticals
e-mail address of the competent person responsible for the Safety Data Sheet
info.sds@leucadiapharma.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
substance or mixture Globally Harmonized Irritant (skin) - Category 2. System [GHS]
2.2 Label elements
SECTION 2 - HAZARDS IDENTIFICATION …continued
Signal word
Warning
Hazard statements
H315 - Causes skin irritation. P302 + P352 - IF ON SKIN: Wash with plenty of soap and water. P321 - Specific treatment (see First Aid information on product label and/or Section 4 of the SDS). P332 + P313 - If skin irritation occurs: Get medical advice/attention. P362 + P364 - Take off contaminate clothing and wash it before reuse.
Precautionary statements
P264 - Wash hands thoroughly after handling. P280 - Wear eye/face protection.
2.3 Other hazards
Sodium tetradecyl sulfate injection is an anionic surfactant, sclerosing agent. Common adverse effects include pain, itching, or ulceration at the injection site. Sloughing and necrosis of tissue may occur following extravasation. Mild systemic effects of headache, nausea, and vomiting have been reported. Less commonly, allergic reactions such as hives, asthma, hay fever, and anaphylactic shock have been reported. No well-controlled studies in pregnant women taking sodium tetradecyl sulfate or developmental toxicity studies in animals were identified. Epidemiology data are conflicting, as congenital anomalies in infants were observed twice as frequently as expected in one report of 95 women treated during the first four months of pregnancy, while no significant increases in anomalies were found among the infants of 606 women treated throughout pregnancy. Note This product/mixture is classified as hazardous under GHS as implemented by
